Biogened (WAR:BGD) Preferred Dividends: zł0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BGD Biogened SA WAR:BGD
73 GF Score
Price zł21.80
GF Value zł23.98
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Biogened Preferred Dividends?

Biogened WAR:BGD -1.80% 73 Preferred Dividends is zł0.0 Mil as of Jun. 2026. GuruFocus rates WAR:BGD with a GF Score™ of 73/100 and a GF Value™ of zł23.98 (Fairly Valued). The stock has 4 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Biogened's preferred dividends for the three months ended in Jun. 2026 was zł0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2026 was zł0.0 Mil.

Biogened  (WAR:BGD) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogened Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Biogened's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biogened Preferred Dividends Chart

Biogened Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biogened Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:BGD
73GF Score
Biogened SA WAR:BGD
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biogened Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of zł0.0 Mil mean?
Biogened (WAR:BGD) has a Preferred Dividends of zł0.0 Mil as of Jun. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Biogened and its competitors.
Is Biogened's Preferred Dividends too high?
Biogened's current Preferred Dividends is zł0.0 Mil. Overall, Biogened has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biogened's Preferred Dividends compare to ZTS and UTHR?
Biogened's Preferred Dividends of zł0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Drug Manufacturers company?
A good Preferred Dividends depends on the Drug Manufacturers industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Biogened and its competitors. Biogened's current Preferred Dividends is zł0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogened stock overvalued right now?
Based on GuruFocus' analysis, Biogened (WAR:BGD) is currently considered Fairly Valued. The stock's GF Value™ is zł23.98, compared to a current price of zł21.80 — trading 9.1% below its estimated fair value. The current Preferred Dividends is zł0.0 Mil. Biogened's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Biogened (WAR:BGD), the current Preferred Dividends is zł0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biogened (WAR:BGD) Overvalued in 2026?

Based on GuruFocus' analysis, Biogened stock appears to be undervalued. The current stock price of zł21.80 is trading 9.1% below its estimated GF Value™ of zł23.98. GuruFocus considers Biogened to be Fairly Valued.

Key valuation signals for WAR:BGD:

  • Preferred Dividends: zł0.0 Mil
  • GF Value™: zł23.98 vs. price of zł21.80 (9.1% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the WAR:BGD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biogened Business Description

Address Ulica Pojezierska 99, Lodz, POL, 91-342
Biogened SA is involved in manufacturing cosmetic and hygiene products. It also designs, produces, and markets safe, effective dermo-cosmetics under the Dermedic brand. The company's products include Dermocosmetics, Thermal water, and Pharmaceutical manufacturing conditions.
73GF Score

Get the complete analysis for WAR:BGD

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł21.80
Price
zł23.98
GF Value